NCT02843802View on ClinicalTrials.gov

Combination of Cryosurgery and NK Immunotherapy for Advanced Liver Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 1, 2016

Primary Completion Date

July 1, 2017

Study Completion Date

July 1, 2019

Conditions
Secondary Malignant Neoplasm of Liver
Interventions
DEVICE

Cryosurgery

Argon-helium cryosurgical system (percutaneous ablation under CT or ultrasound guidance)

BIOLOGICAL

NK Immunotherapy

Natural killer cell (each treatment: about 10 billion cells transfusion in 3 times, i.v.)

Trial Locations (1)

510665

Cancer Institute in Fuda cancer hospital, Guangzhou

All Listed Sponsors
collaborator

Shenzhen Hank Bioengineering Institute

OTHER

lead

Fuda Cancer Hospital, Guangzhou

OTHER

NCT02843802 - Combination of Cryosurgery and NK Immunotherapy for Advanced Liver Cancer | Biotech Hunter | Biotech Hunter